Premarket Decliner
DXR Daxor - Closed End12.24-0.79-6.1%
Premarket:9.49-2.75 (-22.5%)
Daxor Corporation Announces Pricing of $4.0 Million Underwritten Public Offering
Globe NewswireMon, 22-May 8:30 AM
Premarket Gainer
DXR Daxor8.60-0.21-2.4%
Premarket:15.00+6.40 (+74.4%)
Daxor Corporation Announces Engagement with Hospitals and Government for Use of the Blood Volume Analyzer (BVA-100) to Stem COVID-19 Deaths
Globe NewswireMon, 2-Mar 8:00 AM
DXR Daxor6.89+0.20+3.0%
Premarket:8.30+1.41 (+20.5%)
Daxor Corporation Selected for U.S. Army Contract to Develop a Blood Volume Analyzer for Improvement of Combat Casualty Care
Globe NewswireWed, 7-Nov 8:30 AM
DXR Daxor7.78-0.22-2.8%
Premarket:9.70+1.92 (+24.7%)
A New Study Published in The Annals of Thoracic Surgery: Daxor's BVA-100 Device Reveals Unexpected Blood Loss of 38% in Cardiac Surgical Patients Not Detected by Common Test in Use
Globe NewswireThu, 19-Apr 9:00 AM